ELZESKI Trademark

Trademark Overview

On Monday, May 21, 2018, a trademark application was filed for ELZESKI with the United States Patent and Trademark Office. The USPTO has given the ELZESKI trademark a serial number of 87929964. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 8, 2022. This trademark is owned by Bristol-Myers Squibb Company. The ELZESKI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
elzeski

General Information

Serial Number87929964
Word MarkELZESKI
Filing DateMonday, May 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 8, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 30, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, August 8, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 8, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2022SOU EXTENSION 5 GRANTED
Thursday, December 23, 2021SOU EXTENSION 5 FILED
Monday, January 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 23, 2021TEAS EXTENSION RECEIVED
Thursday, June 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 22, 2021SOU EXTENSION 4 GRANTED
Tuesday, June 22, 2021SOU EXTENSION 4 FILED
Tuesday, June 22, 2021TEAS EXTENSION RECEIVED
Thursday, December 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 22, 2020SOU EXTENSION 3 GRANTED
Tuesday, December 22, 2020SOU EXTENSION 3 FILED
Tuesday, December 22, 2020TEAS EXTENSION RECEIVED
Wednesday, July 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 29, 2020SOU EXTENSION 2 GRANTED
Monday, June 29, 2020SOU EXTENSION 2 FILED
Monday, June 29, 2020TEAS EXTENSION RECEIVED
Tuesday, December 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 20, 2019SOU EXTENSION 1 GRANTED
Friday, December 20, 2019SOU EXTENSION 1 FILED
Friday, December 20, 2019TEAS EXTENSION RECEIVED
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, March 31, 2019ASSIGNED TO LIE
Wednesday, March 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 11, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 11, 2018NON-FINAL ACTION E-MAILED
Tuesday, September 11, 2018NON-FINAL ACTION WRITTEN
Tuesday, September 4, 2018ASSIGNED TO EXAMINER
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 24, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

elzeski diseases pharmaceutical human anti preparations disorders organ solid auto immune